275 related articles for article (PubMed ID: 31254640)
1. Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Shinomiya T; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Matsuda Y; Morita T; Koyama A; Yamaguchi T
J Pain Symptom Manage; 2019 Oct; 58(4):645-653. PubMed ID: 31254640
[TBL] [Abstract][Full Text] [Related]
2. Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Matsuoka H; Iwase S; Miyaji T; Kawaguchi T; Ariyoshi K; Oyamada S; Satomi E; Ishiki H; Hasuo H; Sakuma H; Tokoro A; Matsuda Y; Tahara K; Otani H; Ohtake Y; Tsukuura H; Matsumoto Y; Hasegawa Y; Kataoka Y; Otsuka M; Sakai K; Nakura M; Morita T; Yamaguchi T; Koyama A
Support Care Cancer; 2020 Jun; 28(6):2931-2939. PubMed ID: 31761974
[TBL] [Abstract][Full Text] [Related]
3. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol.
Matsuoka H; Clark K; Fazekas B; Oyamada S; Brown L; Ishiki H; Matsuda Y; Hasuo H; Ariyoshi K; Lee J; Le B; Allcroft P; Kochovska S; Fujiwara N; Miyaji T; Lovell M; Agar M; Yamaguchi T; Satomi E; Iwase S; Phillips J; Koyama A; Currow DC
BMJ Open; 2022 Feb; 12(2):e050182. PubMed ID: 35131817
[TBL] [Abstract][Full Text] [Related]
4. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study.
Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T
BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798
[TBL] [Abstract][Full Text] [Related]
5. Attitude of Japanese palliative care specialists towards adjuvant analgesics cancer-related neuropathic pain refractory to opioid therapy: a nationwide cross-sectional survey.
Matsuoka H; Tagami K; Ariyoshi K; Oyamada S; Kizawa Y; Inoue A; Koyama A
Jpn J Clin Oncol; 2019 May; 49(5):486-490. PubMed ID: 30793161
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Tesfaye S; Wilhelm S; Lledo A; Schacht A; Tölle T; Bouhassira D; Cruccu G; Skljarevski V; Freynhagen R
Pain; 2013 Dec; 154(12):2616-2625. PubMed ID: 23732189
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine and pregabalin in neuropathic pain of lung cancer patients.
Gül ŞK; Tepetam H; Gül HL
Brain Behav; 2020 Mar; 10(3):e01527. PubMed ID: 31967742
[TBL] [Abstract][Full Text] [Related]
8. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Tanenberg RJ; Irving GA; Risser RC; Ahl J; Robinson MJ; Skljarevski V; Malcolm SK
Mayo Clin Proc; 2011 Jul; 86(7):615-26. PubMed ID: 21719618
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine Compared with Pregabalin for Diabetic Peripheral Neuropathic Pain Management in Patients with Suboptimal Pain Response to Gabapentin and Treated with or without Antidepressants: A Post Hoc Analysis.
Tanenberg RJ; Clemow DB; Giaconia JM; Risser RC
Pain Pract; 2014 Sep; 14(7):640-8. PubMed ID: 24152185
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial.
Upadhyaya HP; Arnold LM; Alaka K; Qiao M; Williams D; Mehta R
Pediatr Rheumatol Online J; 2019 May; 17(1):27. PubMed ID: 31138224
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Preoperative Administration of Pregabalin and Duloxetine on Cognitive Functions and Pain Management After Spinal Surgery: A Randomized, Double-blind, Placebo-controlled Study.
Altiparmak B; Güzel Ç; Gümüş Demirbilek S
Clin J Pain; 2018 Dec; 34(12):1114-1120. PubMed ID: 30020088
[TBL] [Abstract][Full Text] [Related]
13. Role of Collagen Conduit With Duloxetine and/or Pregabalin in the Management of Partial Peripheral Nerve Injury.
Khan J; Alghamdi H; Anwer MM; Eliav E; Ziccardi V
J Oral Maxillofac Surg; 2016 Jun; 74(6):1120-30. PubMed ID: 26878362
[TBL] [Abstract][Full Text] [Related]
14. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Julious S; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude EB; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Rice ASC; Bouhassira D; Bennett DL; Selvarajah D;
Lancet; 2022 Aug; 400(10353):680-690. PubMed ID: 36007534
[TBL] [Abstract][Full Text] [Related]
15. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain.
Imam MZ; Kuo A; Nicholson JR; Corradini L; Smith MT
Pharmacol Rep; 2020 Oct; 72(5):1418-1425. PubMed ID: 32715433
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety and tolerability of duloxetine vs. pregabalin vs. duloxetine plus gabapentin in patients with diabetic peripheral neuropathic pain.
Irving G; Tanenberg RJ; Raskin J; Risser RC; Malcolm S
Int J Clin Pract; 2014 Sep; 68(9):1130-40. PubMed ID: 24837444
[TBL] [Abstract][Full Text] [Related]
18. Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
Bidari A; Moazen-Zadeh E; Ghavidel-Parsa B; Rahmani S; Hosseini S; Hassankhani A
Daru; 2019 Jun; 27(1):149-158. PubMed ID: 30877484
[TBL] [Abstract][Full Text] [Related]
19. Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain.
Konno S; Oda N; Ochiai T; Alev L
Spine (Phila Pa 1976); 2016 Nov; 41(22):1709-1717. PubMed ID: 27831985
[TBL] [Abstract][Full Text] [Related]
20. Fixed dose combination of low dose pregabalin and duloxetine, or pregabalin monotherapy for neuropathic pain: A double-blind, randomized, parallel-group study.
K K; Dutt S; Rattan P; Dadhania A; Gupta R; Joshi D; Kakkad A; Makwana A; Jha P
F1000Res; 2023; 12():353. PubMed ID: 38618021
[No Abstract] [Full Text] [Related]
[Next] [New Search]
